Ozkan, Huseyin
Di Francesco, Martina
Willcockson, Helen
Valdés-Fernández, José
Di Francesco, Valentina
Granero-Moltó, Froilán
Prósper, Felipe
Decuzzi, Paolo
Longobardi, Lara http://orcid.org/0000-0002-0156-847X
Funding for this research was provided by:
National Institute for Health Care Management Foundation (R01 AR070821)
HORIZON EUROPE European Institute of Innovation and Technology (872648)
Article History
Accepted: 31 August 2022
First Online: 15 September 2022
Declarations
:
: A provisional patent has been filed on the reported RS504393-µPLs agent (IIT Ref. PT210580/UNC Ref. No. 21–0097).
: This study was performed in line with the principles of the Declaration of Helsinki. Animal use protocols were approved by the Animal Care and Use Committee of the University of North Carolina at Chapel Hill NC (IACUC # 20–075.0-C<b>).</b>
: All institutional and national guidelines for the care and use of laboratory animals were followed.